Folitrax 25 (Methotrexate (25mg))

Folitrax 25 Tablet is a pharmaceutical agent utilized in the management of various cancers affecting multiple areas of the body. In addition to its use in oncology, it is indicated for the treatment of rheumatoid arthritis, severe psoriasis that is not well-controlled, and Crohn’s disease. The mechanism of action involves inhibiting the proliferation of dysfunctional cells and modulating immune system function in certain autoimmune disorders. Folitrax 25 may be administered as a standalone therapy or alongside other treatments. It is crucial to adhere strictly to the dosing regimen prescribed by your healthcare provider, as an overdose can result in significant adverse effects. While it may take time—ranging from weeks to months—for therapeutic results to manifest, do not discontinue use without consulting your physician. Among the potential side effects are ulcerative stomatitis, hair loss, decreased blood cell counts, elevated liver enzymes, nausea, and abdominal discomfort. Your physician may recommend folic acid to mitigate certain side effects. If symptoms persist or worsen, it is important to inform your doctor, as there may be strategies to alleviate these effects. Folitrax 25 can compromise your immune response and may lead to complications involving the blood, liver, or renal function. Regular medical evaluations, including blood tests and physical assessments, are typically conducted before and during treatment to monitor for such complications. Prior to starting this medication, it is essential to disclose any pre-existing gastrointestinal, hepatic, or renal conditions, as well as any concurrent medications, to your healthcare provider. The use of Folitrax 25 during pregnancy or lactation is contraindicated due to potential harm to the fetus or nursing infant. Alcohol consumption should also be avoided while on this medication to minimize the risk of liver-related adverse effects.